Search clinical trials for: anaplastic lymphoma kinase (ALK)
Total 19314 results
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
National Cancer Institute (NCI)TerminatedLymphoma, T-Cell | Lymphoma, Large-Cell, Ki-1United States
-
ALK-Abelló A/SSyneos HealthCompletedAllergyFrance, Estonia, Czechia, Lithuania, Poland, Latvia
-
ALK-Abelló A/SSyneos HealthCompletedAllergic Rhinitis | Allergic RhinoconjunctivitisSlovakia, Czechia, Germany
-
ALK-Abelló A/SITEC ServicesCompletedAllergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides PteronyssinusFrance
-
ALK Nordic A/S, Danmark FilialCompletedHandling of Auto-injectorsSweden
-
Sun Yat-sen UniversityRecruitingPediatric Cancer | Anaplastic Lymphoma | MDD | MRD | Lymphoma, NonhodgkinChina
-
Imperial College LondonALK-Abelló A/SCompletedRhinitis, Allergic, SeasonalUnited Kingdom
-
ALK-Abelló A/SInflamax Research IncorporatedCompletedAllergic RhinoconjunctivitisCanada
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Australia, Canada
-
TakedaWithdrawnSolid Tumors | Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumors
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalCompletedCarcinoma, Non-Small-Cell LungDenmark
-
Singapore General HospitalCompletedAngioimmunoblastic T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T-cell Lymphoma (Not Otherwise Specified) | Extranodal NK/T-cell Lymphoma Nasal Type | Enteropathy- Type T-cell Lymphoma | Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative) | Relapsed ALCL (ALK-1 Positive) Post...Singapore, Malaysia, Korea, Republic of
-
Yonsei UniversityNot yet recruitingNon-small Cell Lung CancerKorea, Republic of
-
Alkermes, Inc.Enrolling by invitationSchizophrenia | Bipolar I DisorderUnited States, Argentina, Brazil, Colombia, Mexico
-
Alkermes, Inc.CompletedBipolar I DisorderUnited States
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungFrance
-
University of Milano BicoccaRecruiting
-
Turning Point Therapeutics, Inc.RecruitingLymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS TumorsUnited States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
-
Guangdong Association of Clinical TrialsNot yet recruitingCarcinoma, Non-Small-Cell Lung | Brain Metastases | Leptomeningeal MetastasisChina
-
University of Texas Southwestern Medical CenterNovartis PharmaceuticalsTerminatedALK-positive Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Small-Cell Lung CarcinomaUnited States, Spain, France, Italy, Belgium, Korea, Republic of, Taiwan, United Kingdom, Luxembourg, Australia, Netherlands, Germany, Singapore, Denmark, Russian Federation, Sweden
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Alkermes, Inc.CompletedHealthyUnited States
-
Princess Maxima Center for Pediatric OncologyTakedaRecruitingAnaplastic Large Cell Lymphoma, ALK-Positive | Inflammatory Myofibroblastic Tumor | Other Solid TumorFrance, Netherlands
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited Kingdom, Taiwan, Belgium, Spain, Canada, Italy, Singapore, Japan, Russian Federation, Hong Kong, Thailand, Korea, Republic of, Norway, Australia, France, Sweden, United States, New Zealand
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Australia, Taiwan, Spain, United Kingdom, Korea, Republic of, France, Singapore, Canada, Italy, Netherlands
-
Alkermes, Inc.CompletedSchizophrenia | Alcohol Use DisorderUnited States, Bulgaria, Poland
-
University of California, San FranciscoNovartis Pharmaceuticals; University of California, DavisTerminatedNon-small Cell Lung CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
JI-YOUN HANSeoul National University Hospital; Seoul National University Bundang Hospital and other collaboratorsActive, not recruitingNon Small Cell Lung CancerKorea, Republic of
-
Criterium, Inc.University of Colorado, Denver; Georgetown University; Takeda; University of Pittsburgh and other collaboratorsTerminatedNon-Small Cell Lung CancerUnited States
-
Alkeus Pharmaceuticals, Inc.CompletedAge-related Macular Degeneration | Stargardt Disease | Other Retinal Dystrophies
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Ariad PharmaceuticalsCompletedCarcinoma | Lung Cancer | Non-small Cell Lung Cancer | Advanced MalignanciesUnited States, Canada, Germany, Spain, Taiwan, Korea, Republic of, Switzerland, Hong Kong, Singapore, Italy, Sweden, United Kingdom, France, Netherlands, Denmark, Australia, Norway, Austria, Luxembourg
-
Sun Yat-sen UniversityThe First Affiliated Hospital with Nanjing Medical University; West China Hospital and other collaboratorsRecruitingEnsartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation (EAGLE)Non-Small Cell Lung CancerChina
-
Imperial College LondonALK-Abelló A/SCompletedRhinitis, Allergic, SeasonalUnited Kingdom
-
ALK-Abelló A/SMerck Sharp & Dohme LLCCompletedRhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
Groupe Français de Pneumo-CancérologieTakedaRecruitingNon-small Cell Lung Cancer | ALK Gene Rearrangement PositiveFrance
-
Fundación GECPActive, not recruitingNSCLC | Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIBSpain
-
Fondazione Ricerca TraslazionaleUnknownNon Small Cell Lung Cancer | Metastatic Cancer | Advanced CancerItaly
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Puerto Rico, Australia
-
Alkermes, Inc.CompletedOpioid-induced ConstipationUnited States
-
Hoffmann-La RocheActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Hungary, Australia, Taiwan, China, Denmark, Italy, Spain, Turkey, Japan, France, Korea, Republic of, Germany, Poland, Thailand, Egypt, Russian Federation, Austria, Ukraine, United Kingdom, Romania, Kazakhstan, Bosnia... and more
-
PfizerRecruitingNSCLC | IMT | ALCLChina, Taiwan, Japan, Russian Federation, Italy
-
Universidade Federal do Rio de JaneiroCompleted
-
Sichuan Cancer Hospital and Research InstituteRecruitingALK-positive Non-small Cell Lung Cancer | Real World StudyChina